The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia
Background: Next-generation sequencing (NGS) offers a method for measurable residual disease (MRD) assessment by detecting leukemia-associated genetic mutations. Objective: This study aimed to evaluate the clinical implications and prognostic value of NGS-based MRD assessment in acute myeloid leukem...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-06-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/20406207251349261 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|